Alpha 2.0
Login Register
» Articles » PMID: 21531161

Botulinum Toxin-responsive Oromandibular Dystonia in Cerebrotendinous Xanthomatosis

Overview
Journal Parkinsonism Relat Disord
Specialty Neurology
Date 2011 May 3
PMID 21531161
Citations 4
Authors
Ignacio J Posada
Ana Ramos
Affiliations
Soon will be listed here.
Citing Articles

Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.

Koyama S, Sekijima Y, Ogura M, Hori M, Matsuki K, Miida T J Atheroscler Thromb. 2021; 28(9):905-925.

PMID: 33967188 PMC: 8532057. DOI: 10.5551/jat.RV17055.

Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Wong J, Walsh K, Hayden D, Eichler F J Inherit Metab Dis. 2018; 41(4):647-656.

PMID: 29484516 DOI: 10.1007/s10545-018-0152-9.

Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.

Svoboda M, Christie J, Eroglu Y, Freeman K, Steiner R Am J Med Genet C Semin Med Genet. 2012; 160C(4):285-94.

PMID: 23042642 PMC: 3890258. DOI: 10.1002/ajmg.c.31347.

Leukodystrophy with a cerebellar cystic aspect and intracranial atherosclerosis: an atypical presentation of cerebrotendinous xanthomatosis.

Androdias G, Vukusic S, Gignoux L, Boespflug-Tanguy O, Acquaviva C, Zabot M J Neurol. 2011; 259(2):364-6.

PMID: 21769531 DOI: 10.1007/s00415-011-6167-x.